K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
National Kidney Foundation Kidney Disease Outcomes Quality Initiative
National Kidney Foundation Kidney Disease Outcomes Quality Initiative (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 (Suppl 3): S1-S201
Is low plasma 25-(OH) vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
Ghazali A et al. (1995) Is low plasma 25-(OH) vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int 55: 2169-2177
Vitamin D insufficiency and deficiency in chronic kidney disease: A single center observational study
González EA et al. (2004) Vitamin D insufficiency and deficiency in chronic kidney disease: a single center observational study. Am J Nephrol 24: 503-510
Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States
LaClair RE et al. (2005) Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45: 1026-1033
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
Levin A et al. (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71: 31-38
Renal osteodystrophy in children: Etiology and clinical aspects
Eds Fine RN and Gruskin AB Philadelphia: WB Saunders
Mehls O (1984) Renal osteodystrophy in children: etiology and clinical aspects. In End Stage Renal Disease in Children, 227-250 (Eds Fine RN and Gruskin AB) Philadelphia: WB Saunders
Vitamin D: The underappreciated D-lightful hormone that is important for skeletal and cellular health
Holick MF (2002) Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 9: 87-98
Comparison of 1 alpha- hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: Greater effect of 25-hydroxycholecalciferol on bone mineralization
Fournier A et al. (1979) Comparison of 1 alpha- hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization. Kidney Int 15: 196-204
Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy
Goodman WG et al. (1994) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46: 1160-1166